Spectranetics (SPNC) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq touch new peaks as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Nasdaq notches record high close as investors focus on earnings
- Emera and Canadian Utilities agree to merge in $72B all-share deal
Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million
April 23, 2015 4:03 PM EDTExpands Stellarex Program to Below the Knee Market
Updates 2015 Outlook
COLORADO SPRINGS, Colo., April 23, 2015 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq: SPNC) today reported financial results for the three months ended March 31, 2015. Highlights of the quarter, all compared with the three months ended March 31, 2014 include:
Revenue of $57.4 million, up 45% (47% constant currency1) Vascular Intervention revenue of $36.5 million grew 82% (84% constant currency) U.S. peripheral atherectomy revenue grew 16% AngioSculpt® revenue of $14.0 million achieved Lead Management revenue of $16.4 million increased 14% (16% constant... More


